Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC

NCT06350162 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Extensive Stage Lung Small Cell Cancer

Interventions

DRUG: Serplulimab
RADIATION: Chest Radiation

Sponsor

Zhejiang Cancer Hospital